您好，欢迎来到易推广！ 请登录 免费注册

上海陶术生物科技有限公司 主营产品：生物试剂,实验服务等

当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示

企业档案

会员类型：会员

已获得易推广信誉   等级评定
139成长值

(0 -40)基础信誉积累，可浏览访问

(41-90)良好信誉积累，可接洽商谈

(91+  )优质信誉积累，可持续信赖

易推广会员：5年

工商认证 【已认证】

最后认证时间：

注册号： 【已认证】

法人代表： 【已认证】

企业类型：生产商 【已认证】

注册资金：人民币万 【已认证】

产品数：86101

参观次数：3872399

手机网站：http://m.yituig.com/c135739/

旗舰版地址：http://tsbiochem.app17.com

自主品牌

自主品牌

已选条件

  • T77080Manfidokimab；化合物 ManfidokimabManfidokimab

    Manfidokimab (AK120), an IgG4 monoclonal antibody targeting the interleukin 4 receptor alpha (IL-4Rα), demonstrates therapeutic efficacy as detailed in reference [1].

    价 格：￥电议型 号：T77080产 地：中国大陆

  • T7708DL-Buthionine-(S,R)-sulfoximine丁基硫Butionine sulfoximine|||丁基硫|||NSC 381100|||D,L-Buthionine-(S,R)-su

    DL-Buthionine-(S,R)-sulfoximine (Butionine sulfoximine) is an inhibitor of γ-glutamylcysteine synthetase for the treatment of solid tumors.

    价 格：￥电议型 号：T7708产 地：中国大陆

  • T77079Manelimab；化合物 ManelimabManelimab

    Manelimab is a monoclonal antibody that inhibits programmed death-ligand 1 ( PD-L1 ) [1] .

    价 格：￥电议型 号：T77079产 地：中国大陆

  • T77078Maftivimab；化合物 MaftivimabMaftivimab

    Maftivimab (REGN3470-3471-3479), also known as Atoltivimab, Odesivimab (Inmazeb), is a Filovirus inhibitor and a Food and Drug Administration (FDA)-approved agent for the research of Zaire ebolavirus infection [1].

    价 格：￥电议型 号：T77078产 地：中国大陆

  • T77077Lutikizumab；化合物 LutikizumabLutikizumab

    Lutikizumab (ABT-981) is a dual variable domain immunoglobulin targeting and inhibiting both IL-1α and IL-1β. This compound is under investigation for its potential application in osteoarthritis research [1].

    价 格：￥电议型 号：T77077产 地：中国大陆

  • T77075Spartalizumab；斯巴达珠单抗PDR001；PDR001

    Spartalizumab (PDR001) is a humanized immunoglobulin 4 monoclonal antibody that selectively binds to PD-1 at low concentrations and shows high activity. Spartalizumab blocks the interaction with PD-L1 and PD-L2, and can be used to study undifferentiated thyroid cancer (ATC).

    价 格：￥电议型 号：T77075产 地：中国大陆

  • T77074Lulizumab pegol；化合物 Lulizumab pegolLulizumab pegol

    Lulizumab pegol (BMS-931699) is an antagonist anti-CD28 antibody that effectively inhibits T-cell proliferation, making it a potential therapeutic agent for kidney transplantation and autoimmunity disease research [1].

    价 格：￥电议型 号：T77074产 地：中国大陆

  • T77073Losatuxizumab；化合物 LosatuxizumabLosatuxizumab

    Losatuxizumab (ABT-806), an anti-EGFR monoclonal antibody, exhibits selective binding affinity towards various EGFR forms, with EC50 values of 0.96 nM for the wild-type EGFR, 0.09 nM for the C271A,C283A mutant, 0.12 nM for EGFRvIII, and 0.66 nM for EGFR1-501. It is utilized in research targeting EGFR-expressing cancers [1] [2].

    价 格：￥电议型 号：T77073产 地：中国大陆

  • T77072Lorigerlimab；化合物 LorigerlimabLorigerlimab

    Lorigerlimab (MGD019) is a bispecific IgG4 dual-affinity re-targeting (DART) antibody that blocks both PD-1 and CTLA-4, enhancing T-cell responses. It is under investigation for the treatment of metastatic castration-resistant prostate cancer (mCRPC) [1] [2] [3].

    价 格：￥电议型 号：T77072产 地：中国大陆

  • T77071Lonigutamab；化合物 LonigutamabLonigutamab

    Lonigutamab (hz208F2-4), a humanized monoclonal antibody targeting IGF-1R, facilitates the creation of antibody-drug conjugates (ADC) [1].

    价 格：￥电议型 号：T77071产 地：中国大陆

  • T77070Loncastuximab；化合物 LoncastuximabLoncastuximab

    Loncastuximab (RB4v1.2), an anti-CD19 monoclonal antibody, exhibits antitumor properties and holds potential for treating non-Hodgkin´s lymphoma (NHL), specifically diffuse large B-cell lymphoma (DLBCL) [1] [2].

    价 格：￥电议型 号：T77070产 地：中国大陆

  • T7707Pencycuron；戊菌隆Monceren；Monceren|||戊菌隆

    Pencycuron (Monceren) is a phenylurea fungicide.

    价 格：￥电议型 号：T7707产 地：中国大陆

  • T77069Lomtegovimab；化合物 LomtegovimabLomtegovimab

    Lomtegovimab (BI 767551), a humanized monoclonal antibody targeting the SARS-CoV-2 spike glycoprotein, exhibits antiviral efficacy by binding to and neutralizing the virus. This compound holds potential for COVID-19 research [1] [2].

    价 格：￥电议型 号：T77069产 地：中国大陆

  • T77068Lodapolimab；化合物 LodapolimabLodapolimab

    Lodapolimab (LY3300054) is an IgGλ anti- PD-1 monoclonal antibody [1] .

    价 格：￥电议型 号：T77068产 地：中国大陆

  • T77067Livmoniplimab；化合物 LivmoniplimabLivmoniplimab

    Livmoniplimab (ABBV-151; ARGX-115), a potent humanized monoclonal antibody targeting LRRC32 (GARP)/TGFβ1, inhibits LRRC32-mediated activation of latent TGFβ1. This compound shows promise for cancer research [1].

    价 格：￥电议型 号：T77067产 地：中国大陆

  • T77066Lilotomab；化合物 LilotomabLilotomab

    Lilotomab (HH1), a murine anti-CD37 monoclonal antibody, demonstrates anti-tumor activity by reducing clonogenic survival [1].

    价 格：￥电议型 号：T77066产 地：中国大陆

  • T77065Ligufalimab；化合物 LigufalimabLigufalimab

    Ligufalimab (AK 117), a humanized IgG4 monoclonal antibody targeting CD47, does not lead to red blood cell (RBC) hemagglutination but promotes phagocytosis and exhibits anti-tumor activity [1].

    价 格：￥电议型 号：T77065产 地：中国大陆

  • T77064Licaminlimab；化合物 LicaminlimabLicaminlimab

    Licaminlimab (OCS-02) is a single-chain anti-TNF alpha antibody fragment that targets TNF alpha, an inflammatory cytokine produced by macrophages and monocytes during inflammation [1].

    价 格：￥电议型 号：T77064产 地：中国大陆

  • T77063Libivirumab；化合物 LibivirumabLibivirumab

    Libivirumab (17.1.41), a humanized monoclonal antibody targeting hepatitis B virus (HBV), demonstrates neutralizing activity with half maximal inhibitory concentrations (IC50) of 35 ng/mL for HBsAg and 130 ng/mL for HBeAg, respectively [1].

    价 格：￥电议型 号：T77063产 地：中国大陆

  • T77062Levilimab；化合物 LevilimabLevilimab

    Levilimab (BCD-089), a fully human monoclonal antibody targeting the interleukin-6 receptor (IL-6R), serves as an inflammation-reducing agent. This compound is utilized in the study of rheumatoid arthritis [1].

    价 格：￥电议型 号：T77062产 地：中国大陆

11234567891017下一页共17页

展台首页| 公司简介| 供应产品| 产品目录| 公司动态| 荣誉证书| 招聘信息| 技术中心| 联系我们| 会员管理

易推广  设计制作，未经允许翻录必究.Copyright(C) 2009 http://www.yituig.com, All rights reserved.

以上信息由企业自行提供，信息内容的真实性、准确性和合法性由相关企业负责，易推广对此不承担任何责任.   总访问量：3872399

中国彩虹热线

快速导航

返回顶部
在线咨询

提交